Given the year’s choppy venture waters and public market correction, digital health investors are holding back from the market, waiting to strike once things stabilize, Rock Health reports. Q3’s low funding numbers—the lowest quarterly funding total in the past 11 quarters—reflect that sentiment. Yet, even though the market isn’t the same as it was, this quarter has featured some standout digital health activity, including major acquisitions by Amazon and CVS, and Akili’s SPAC close, this year’s first digital health public exit.
A few key themes emerged throughout Q3: 1) smaller checks across the board, 2) a focus on early-stage funding, 3) reprioritization of technology investments, and 4) an exit market that’s beginning to thaw. Each hints at the type of activity that may be seen in Q4 and the early days of 2023. Read more.
